Endo Inc. (NDOI)
| Market Cap | 1.63B |
| Revenue (ttm) | 1.76B |
| Net Income (ttm) | 5.64B |
| Shares Out | 76.21M |
| EPS (ttm) | 44.89 |
| PE Ratio | 0.49 |
| Forward PE | 7.03 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2,300 |
| Average Volume | 312,527 |
| Open | 21.51 |
| Previous Close | 21.30 |
| Day's Range | 21.30 - 21.51 |
| 52-Week Range | 21.30 - 31.40 |
| Beta | n/a |
| RSI | 23.00 |
| Earnings Date | May 6, 2025 |
About Endo Inc.
Endo Inc., a specialty pharmaceutical company, develops, manufactures, markets, and sells various pharmaceutical products in the United States and internationally. The company offers products for the treatment of conditions in urology, orthopedics, and endocrinology. It is involved in the developing additional indications for XIAFLEX in clinical development, including plantar fibromatosis and plantar fasciitis, as well as others are in pre-clinical development, including arthrofibrosis of the knee following knee arthroplasty. The company offers... [Read more]
Full Company ProfileFinancial Performance
Financial StatementsNews
Endo to Report First Quarter 2025 Financial Results on May 7, 2025
MALVERN, Pa. , April 7, 2025 /PRNewswire/ -- Endo, Inc. (OTCQX: NDOI) ("Endo" or the "Company") announced today that it will report first quarter 2025 financial results on May 7, 2025, prior to market...
Endo Launches Spatial Computing Simulator to Create a Fully Immersive Learning Environment for Hand Specialists
- Endo is the first pharmaceutical company to launch an external spatial computing program.- The Spatial Computing Injection Simulator allows hand specialists to interact simultaneously with both phys...
Endo Presents Dupuytren Contracture Data at the IFSSH and IFSHT Triennial Congress
MALVERN, Pa. , March 24, 2025 /PRNewswire/ -- Endo, Inc. (OTCQX: NDOI) announced today that data related to the use of XIAFLEX® (collagenase clostridium histolyticum, or CCH) for the treatment of recu...
ENDO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Endo, Inc. - NDOI
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of End...
Endo International plc (ENDPQ) Q4 2024 Earnings Call Transcript
Endo International plc (OTC:ENDPQ) Q4 2024 Earnings Conference Call March 13, 2025 8:00 AM ET Company Participants Laure Park - Senior Vice President of Investor Relations and Corporate Affairs of End...
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Endo, Inc.
NEW YORK , March 13, 2025 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Endo, Inc. (OTCQX: NDOI) and its board of directors concerning the proposed acquisitio...
$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Endo, Inc. - NDOI
NEW YORK , March 13, 2025 /PRNewswire/ -- Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2024 IS...
NDOI Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Endo, Inc. Is Fair to Shareholders
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Endo, Inc. (OTCQX: NDOI) and Mallinckrodt plc is fair to Endo shareholders. Under the t...
Shareholder Alert: The Ademi Firm Investigates Whether Endo, Inc. Is Obtaining a Fair Price for Its Public Shareholders
MILWAUKEE--(BUSINESS WIRE)--The Ademi Firm is investigating Endo (OTCQX: NDOI) for possible breaches of fiduciary duty and other violations of law in its transaction with Mallinckrodt. Click here to l...
Mallinckrodt, Endo Merger to Create Diversified Pharmaceuticals Firm
Drugmaker Mallinckrodt struck a deal to buy Endo in an effort to build a diversified pharmaceuticals company with a hefty U.S. footprint.
Mallinckrodt and Endo plan merger as they look to recover from opioid litigation
The new entity will be listed on the New York Stock Exchange and is expected to generate pro forma revenue of $3.6 billion in 2025 and at least $150 million of annual operating synergies by year three...
Drugmakers Mallinckrodt and Endo to merge in nearly $7 billion deal
Mallinckrodt and Endo , drugmakers with a shared history of facing U.S. opioid litigation, have agreed to merge in a deal valued at nearly $7 billion.
Endo Reports Fourth-Quarter and Full-Year 2024 Financial Results
Endo achieved 2024 revenues and adjusted EBITDA expectations, while progressing the Company's strategic priorities XIAFLEX® hit record revenues of $516 million in 2024, up 9% versus 2023 The Company p...
Mallinckrodt and Endo to Combine to Create a Global, Scaled, Diversified Pharmaceuticals Leader
Transaction Brings Together Two Highly Complementary Businesses to Broaden Patient Access and Develop New Therapies to Address Unmet Patient Needs Combined Company Expected to Benefit from Immediate S...
Drugmakers Mallinckrodt, Endo in talks to merge, Bloomberg News reports
Mallinckrodt Pharmaceuticals and Endo are exploring a potential merger that could be valued at about $7 billion, Bloomberg News reported on Wednesday, citing people with knowledge of the matter.
Endo Announces Peyronie's Disease Presentation at the Annual Meeting of the Southeastern Section of the American Urological Association
MALVERN, Pa. , March 12, 2025 /PRNewswire/ -- Endo, Inc. (OTCQX: NDOI) announced today that a post hoc data analysis of a Phase 3 clinical trial of XIAFLEX® (collagenase clostridium histolyticum, or C...
Endo Announces Divestiture of International Pharmaceuticals Business
MALVERN, Pa. , March 11, 2025 /PRNewswire/ -- Endo, Inc. ("Endo" or the "Company") (OTCQX: NDOI) today announced it has entered into a definitive agreement to divest its International Pharmaceuticals ...
Endo Reschedules Release of Fourth Quarter and Full Year 2024 Earnings Results and Conference Call
MALVERN, Pa. , March 10, 2025 /PRNewswire/ -- Endo, Inc. (OTCQX: NDOI) ("Endo" or the "Company") announced today that it has rescheduled the release of its fourth quarter and full year 2024 financial ...
Endo Group, LLC d/b/a Endo Group, Garden City SurgiCenter, and Syosset SurgiCenter Data Breach - Levi & Korsinsky, LLP Launches Investigation
NEW YORK CITY, NY / ACCESS Newswire / February 27, 2025 / Endo Group, LLC d/b/a Endo Group, Garden City SurgiCenter, and Syosset SurgiCenter recently disclosed that it suffered a data breach that comp...
Endo Group, LLC d/b/a Endo Group, Garden City SurgiCenter, and Syosset SurgiCenter Data Breach - Levi & Korsinsky, LLP Launches Investigation
NEW YORK, NY / ACCESS Newswire / February 26, 2025 / Endo Group, LLC d/b/a Endo Group, Garden City SurgiCenter, and Syosset SurgiCenterrecentlydisclosed that it suffered a data breach that compromised...
INVESTIGATION ALERT: Levi & Korsinsky, LLP Announces Investigation of Endo Group, LLC d/b/a Endo Group, Garden City SurgiCenter, and Syosset SurgiCenter Data Breach
NEW YORK, NY / ACCESS Newswire / February 25, 2025 / Endo Group, LLC d/b/a Endo Group, Garden City SurgiCenter, and Syosset SurgiCenter recently disclosed that it suffered a data breach that compromis...
INVESTIGATION ALERT: Levi & Korsinsky, LLP Announces Investigation of Endo Group, LLC d/b/a Endo Group, Garden City SurgiCenter, and Syosset SurgiCenter Data Breach
NEW YORK, NY / ACCESS Newswire / February 24, 2025 / Endo Group, LLC d/b/a Endo Group, Garden City SurgiCenter, and Syosset SurgiCenter recently disclosed that it suffered a data breach that compromis...
INVESTIGATION ALERT: Levi & Korsinsky, LLP Announces Investigation of Endo Group, LLC d/b/a Endo Group, Garden City SurgiCenter, and Syosset SurgiCenter Data Breach
NEW YORK, NY / ACCESS Newswire / February 24, 2025 / Endo Group, LLC d/b/a Endo Group, Garden City SurgiCenter, and Syosset SurgiCenter recently disclosed that it suffered a data breach that compromis...
Endo Group, LLC d/b/a Endo Group, Garden City SurgiCenter, and Syosset SurgiCenter Data Breach under Investigation by Levi & Korsinsky, LLP
NEW YORK, NY / ACCESS Newswire / February 21, 2025 / Endo Group, LLC d/b/a Endo Group, Garden City SurgiCenter, and Syosset SurgiCenter recently disclosed that it suffered a data breach that compromis...
Endo to Report Fourth Quarter and Full Year 2024 Financial Results on March 11, 2025
MALVERN, Pa. , Feb. 21, 2025 /PRNewswire/ -- Endo, Inc. (OTCQX: NDOI) ("Endo" or the "Company") announced today that it will report fourth quarter and full year 2024 financial results on March 11, 202...